Neuronetics vs Xtant Medical
Neuronetics reported revenue of $149 million in fiscal 2025, about the same as Xtant Medical's $134 million in fiscal 2025. Neuronetics' revenue grew 99.2% in its latest year, and Xtant Medical's grew 14.2%. Neuronetics had an operating margin of -21.1%, against 5.4% at Xtant Medical. Free cash flow was −$21 million at Neuronetics and $10 million at Xtant Medical.
Side by side
| Neuronetics | Xtant Medical | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $149M | $134M |
| Revenue growth | 99.2% | 14.2% |
| Revenue growth a year, last 5 years | 24.8% | 20.2% |
| Gross margin | 48.5% | 62.9% |
| Operating margin | −21.1% | 5.4% |
| Net margin | −26.1% | 3.7% |
| Free cash flow | −$21M | $10M |
| Free cash flow margin | −14.2% | 7.6% |
| Return on capital | −37.5% | 10.0% |
| Net debt to EBITDA | — | −0.5x |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 107.8% | 12.2% |
| Last close | $1.24 | $0.22 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $4.8 million, sold $270,405 | — |
| Piotroski F-score | 4 of 9 | 8 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
NeuroneticsXtant Medical
Operating margin
Percent of revenue
NeuroneticsXtant Medical
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
NeuroneticsXtant Medical
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Neuronetics and Xtant Medical pages.